Abstract
Intraoperative fluorescence imaging (IFI) can improve real-time identification of cancer cells during an operation. Phase I clinical trials in thoracic surgery have demonstrated that IFI with second window indocyanine green (TumorGlow®) can identify subcentimeter pulmonary nodules, anterior mediastinal masses, and mesothelioma, while the use of a folate receptor-targeted near-infrared agent, OTL38, can improve the specificity for diagnosing tumors with folate receptor expression. Here, we review the existing preclinical and clinical data on IFI in thoracic surgery.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 344-355 |
| Number of pages | 12 |
| Journal | Journal of Surgical Oncology |
| Volume | 118 |
| Issue number | 2 |
| DOIs | |
| State | Published - Aug 1 2018 |
Keywords
- OTL38
- indocyanine green (ICG)
- intraoperative fluorescence imaging (IFI)
- near-infrared (NIR) fluorescence imaging
- thoracic surgery
ASJC Scopus subject areas
- Surgery
- Oncology
Fingerprint
Dive into the research topics of 'Intraoperative fluorescence imaging in thoracic surgery'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS